Bioceres Crop Solutions Corp. · NASDAQ:BIOX
Bioceres Crop Solutions — LD Micro Conference 2020
18 slides from Bioceres Crop Solutions's conference presentation, September 2020
Slide 1: LD Micro Conference
LD Micro Conference Virtual Event September 2020
Slide 2: Disclaimer and Forward-looking Statement
Disclaimer and Forward-looking Statement This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, assets, business, debt or other financial instruments of the Company or
Slide 3: Overview
Overview We are a fully-integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality A Compelling Biotech story By the Numbers Addressing global agriculture challenges through a carbon neutral approach $ 175M $ 41M revenues1 Adj. EB
Slide 4: History
History 43 years of experience utilizing multiple technological approaches to develop and commercialize products that enhance crop quality and productivity Bioceres consolidates 80% of Rizobacter HB4® soybean Regulatory approval Regulatory approval of collaboration for HB4® soybean in HB4® soybean i
Slide 5: International Expansion
International Expansion Bioceres Crop Solutions primarily sells products within South America, however the company is well positioned to follow the geographical exposure of the global soybean and wheat footprint A well-positioned commercial footprint, backed by local and international market share:
Slide 6: Assets Base
Assets Base Significant realized investments in modern production capacity , R&D backed by patents, brands and product registration in several countries, provides a solid platform to support continued organic growth Seed & Integrated Products Crop Nutrition Crop Protection Proprietary brands in
Slide 7: Business Segments and Product Portfolio
Business Segments and Product Portfolio Leading positions and multiple growth levers Segment Crop Protection Crop Nutrition Seed & Integrated Products Increase Full range of pest Nitrogen-fixing Micro-beaded Full seed treatment EcoSoy and effectiveness and control molecules biologicals t
Slide 8: HB4® Technology
HB4® Technology Only available technology for drought tolerance in soybean-wheat cropping systems Confidential Information 8
Slide 9: The HB4® Technology Performance
The HB4® Technology Performance Bioceres’ proprietary HB4® technology is the only available technology for drought tolerance in soybean-wheat cropping systems EcoSoy EcoWheat HB4 prepares the plant to better withstand Combines validated HB4 technology with adverse environmental conditions Glufosinat
Slide 10: HB4® Value Creation to Farmers
HB4® Value Creation to Farmers 34 Mha 29 Mha 20 Mha Additional crop value created by HB4® 160 $/ha 55 $/ha Combination of EcoWheat and EcoSoy for Argentina. Brazil and US, EcoSoy only Confidential Information 10
Slide 11: HB4® Regulatory Approvals
HB4® Regulatory Approvals Regulatory approval in over 80% of the global soybean market (AR, BR and US), and pending approvals in 6 other countries Regulatory approval obtained Approval requested Confidential Information 11
Slide 12: HB4® and the EcoSeed Concept
HB4® and the EcoSeed Concept Isolated and characterized microbial Integration of strains into HB4 varieties Integrated/customized strains that promote growth for and other biological assets, to create seed product with data different environments non-replicable seed products interface Confidential I
Slide 13: The HB4® Program
The HB4® Program The HB4® Program is an identity preserved production system for soybean and wheat. The Program establishes good agricultural practices for growers, which enhanced by our technologies, significantly contribute to the transition of agriculture towards carbon neutrality Certified Susta
Slide 14: Company Performance
Company Performance Proven track-record in delivering solid financial performance Revenues ($M) Adjusted EBITDA ($M) 161 175 41 41 134 87 22 14 FY17 FY18 FY19 LTM 03/20 FY17 FY18 FY19 LTM 03/20 1. Financials presented correspond to unaudited financials for 3Q20 LTM (ended March 31th, 2020) Confident
Slide 15: Financial Debt Position
Financial Debt Position Strengthened Balance Sheet and Increased Liquidity Net Debt 2.37x 2.24x 2.14x 2.23x 2.30x LTM EBITDA 79.6 $ million 93.5 90.3 92.8 92.1 86.8 40.1 16.9 37.1 32.5 52.6 83.8 63.5 64.1 66.9 14.9 66.4 10.5 7.8 9.8 3Q19 4Q19 1Q20 2Q20 3Q20 Current debt Non-current debt Cash & Equiv
Slide 16: Unaudited Interim Condensed Consolidated Statements of Financial Position
Annex I Unaudited Interim Condensed Consolidated Statements of Financial Position As of March 31, 2020 and June 30, 2019 (Amounts in US Dollars) ASSETS 03/31/2020 06/30/2019 LIABILITIES 03/31/2020 06/30/2019 CURRENT ASSETS CURRENT LIABILITIES Cash and cash equivalents 48,178,287 3,450,873 Trade and
Slide 17: Unaudited Interim Condensed Consolidated Statements of Comprehensive Income
Annex II Unaudited Interim Condensed Consolidated Statements of Comprehensive Income For the three-month and nine-month periods ended March 31, 2020 and 2019 (Amounts in US Dollars) Three-month period ended Three-month period ended Nine-month period ended Nine-month period ended 03/31/2020 03/31/201
Slide 18: Contact us
Contact us Investor Relations Investorrelations@biocerescrops.com (54) 0341 4861100 Investors.biocerescrops.com 18